People · Operator
Named in public records as an officer, director or promoter · active 2009–2017 · Biotechnology, Pharmaceuticals, Other, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Adaptive Biotechnologies Corp | — | Biotechnology | Series D+ | $614.0M | $8.0B | 2012 |
| Revalesio Corp | — | Pharmaceuticals | Series B | $103.4M | $624.8M | 2012 |
| Stratos Genomics Inc. | — | Biotechnology | Series B | $58.9M | $800.0M | 2010 |
| VERATECT Corp | — | Other | Series A | $7.6M | $63.7M | 2009 |
| Goodwell Fitness Network, Inc. | — | Other Technology | Pre-Seed | $125K | $5.3M | 2015 |
Lee Huntsman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Lee Huntsman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Jeffrey Smith | 1 | 11 |
| James Wilson | 1 | 10 |
| Heiner Dreismann | 1 | 6 |
| John Carleton | 1 | 5 |
| Chad Robins | 1 | 5 |
| Arnold Levine | 1 | 4 |
| Peter Neupert | 1 | 4 |
| Scott Walchek | 1 | 4 |
| John Stuelpnagel | 1 | 3 |
| Dennis Weston | 1 | 3 |
| Stephen Rose | 1 | 3 |
| TROY ALSTEAD | 1 | 2 |
| Craig Weissman | 1 | 2 |
| Eric Russell | 1 | 2 |
| Allan Stephan | 1 | 2 |
| Robert S Hart | 1 | 2 |
| Dennis S Weston | 1 | 2 |
| Harlan Robins | 1 | 2 |
| Chris Carlson | 1 | 2 |
| Harold Kawaguchi | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.